Aeglea BioTherapeutics is a Austin, Texas-based pharmaceutical company developing drugs for the treatment of tumors.
February 3, 2021
The company announced that the company's chief financial officer, Charles N. York II, will be leaving the company effective February 12, 2021 to serve in an expanded chief operating officer and chief financial officer role at an emerging oncology company.